Skip to main content

Table. 4 Outcomes and hepatorenal function in matched cohort

From: Bilirubin adsorption versus plasma exchange for hyperbilirubinemia in patients after cardiac surgery: a retrospective study

Variable Bilirubin adsorption (n = 14) Plasma exchange (n = 14) P value
Death (n, %) 10, 71.4% 14, 100.0% 0.049
CRRT (n, %) 12, 85.7% 12, 85.7%
IABP (n, %) 3, 21.4% 8, 57.15% 0.060
ECMO (n, %) 3, 21.4% 3, 21.4%
Re-intubation (n, %) 9, 64.2% 10, 71.4% 0.500
Septic shock (n, %) 5, 35.7% 4, 28.6% 0.500
Ventricular arrhythmias (n, %) 9, 64.2% 6, 42.9% 0.225
Hepatic encephalopathy (n, %) 5, 35.7% 13, 92.9% 0.002
Peak VIS after adsorption/exchange 47.3 ± 5.9 62.9 ± 19.8 0.013
Peak lac adsorption/exchange (mmol/L) 8.4 ± 2.2 10.1 ± 2.1 0.045
After adsorption/exchange    
ALT 28.9 (19.4–64.0) 42.1 (32.9–94.0) 0.021
AST 58.0 (46.6–74.5) 76.3 (60.3–101.7) 0.012
GGT 69.0 (20.0–118.5) 79.0 (30.0–125.3) 0.667
TBil 162.9 ± 76.3 235.2 ± 82.9 0.024
DBil 90.4 ± 35.2 139.1 ± 53.5 0.009
LDH 394.5 ± 127.8 435.1 ± 161.7 0.467
 Serum Creatinine 80.1 ± 11.9 107.8 ± 22.8 0.001
 BUN 10.3 ± 2.8 14.5 ± 4.3 0.010
 C-creative protein 83.5 ± 15.8 151.6 ± 49.2 0.018